DEEPSEAPHARMA ApS: Financial statements 2023
CVR: 32561365
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
DEEPSEAPHARMA ApS (CVR 32561365) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 4,435,382 and a net result of DKK 2,176,566 compared with DKK 605,012 the year before. That is an increase of 71.3% compared with the year before. Equity in the 2023 report amounted to DKK 3,218,760. The solvency ratio was 48.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 4,435,382
- Profit/Loss
- DKK 2,176,566
- Equity
- DKK 3,218,760
- Total Assets
- DKK 6,656,696
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 4.4 mio. | 2.2 mio. | 3.2 mio. | 1 |
| 2022 | - | 2.6 mio. | 605 t. | 1.6 mio. | 2 |
| 2021 | - | 3.1 mio. | 1.1 mio. | 1.8 mio. | 2 |
| 2020 | - | 2.2 mio. | 912 t. | 1.5 mio. | 2 |
| 2019 | - | 1.8 mio. | 730 t. | 1.1 mio. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
DEEPSEAPHARMA ApS has published its annual report for 2022. Gross profit came to DKK 2,588,681, and the net result was DKK 605,012.
About DEEPSEAPHARMA ApS
DEEPSEAPHARMA ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2009. The company is registered under the industry Engroshandel med fisk og fiskeprodukter. The management consists of Kristian Rousku Andersen. The company is owned by DISOP HOLDING ApS. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 4,910,748 and a net result of DKK 3,145,783 compared with DKK 2,246,538 the year before. Equity in the 2025 report amounted to DKK 7,011,081.